XML 56 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
Derivative Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2012
Derivative Financial Instruments [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]
The following table summarizes the fair value of derivative instruments recorded in the consolidated balance sheets as of December 31, 2012 and 2011 (dollars in thousands): 
 
 
 
 
Fair Value
 
 
Balance Sheet Location
 
2012
 
2011
Asset Derivatives:
 
 
 
 
 
 
Derivatives designated as hedges:
 
 
 
 
 
 
Interest rate swap agreements
 
Other assets, net
 
$
4,302

 
$

Derivatives not designated as hedges:
 
 
 
 
 
 
Cross-currency swap agreements
 
Prepaid expenses and other
 
$
255

 
$

Liability Derivatives:
 
 
 
 
 
 
Derivatives designated as hedges:
 
 
 
 
 
 
Interest rate swap agreements
 
Accrued expenses
 
$
3,778

 
$
4,143

Interest rate swap agreements
 
Other long-term liabilities
 
885

 
2,882

Total derivatives designated as hedges
 
 
 
$
4,663

 
$
7,025

Derivatives not designated as hedges:
 
 
 
 
 
 
Cross-currency swap agreements
 
Accrued expenses
 
$

 
$
7,170

Cross-currency swap agreements
 
Other long-term liabilities
 
143

 

Total derivatives not designated as hedges
 
 
 
$
143

 
$
7,170

Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]
The following table shows the effect of the Company’s derivative instrument designated as a cash flow hedge for the years ended December 31, 2012 and 2011 in other comprehensive income/(loss) (OCI) (dollars in thousands): 
 
 
Total Cash Flow
Hedge OCI Activity,
Net of Tax
 
 
2012
 
2011
Derivatives Designated as Cash Flow Hedges:
 
 
 
 
Effective portion of changes in fair value recognized in OCI:
 
 
 
 
Interest rate swap agreement
 
$
4,053

 
$
1,334

Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location
The following table shows the effect of the Company’s derivative instruments not designated as hedges for the years ended December 31, 2012 and 2011 in the consolidated statements of operations (dollars in thousands): 
 
 
 
Amount Recognized in Earnings
 
Location of Amount Recognized
in Earnings
 
2012
 
2011
Derivative Instruments Not Designated as Hedges:
 
 
 
 
 
Cross-currency swap agreements
Interest (expense)/income
 
$
(4,638
)
 
$
(5,935
)
Cross-currency swap agreements
Other income/(expense), net
 
303

 
246

Contingent forward sale contract
Contingent forward sale contract mark-to-market expense
 
(50,106
)
 

 
 
 
$
(54,441
)
 
$
(5,689
)